Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

Annals of Surgery

Volumn 224, Issue 4, 1996, Pages 509-522

  Bismuth, Henry ^a   Adam, René ^a   Lévi, Fraņcis ^a   Farabos, Christian ^a   Waechter, Fabio ^a   Castaing, Denis ^a   Majno, Pietro ^a   Engerran, Luc ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL PROTOCOL; COLORECTAL CANCER; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE;

EID: 0029794696     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199610000-00009     Document Type: Article

References (31)

1. Steele G Jr, Ravikumar TS. Resection of hepatic mestastases from colorectal cancer: biologic perspectives. Ann Surg 1989; 210:127-138.
2. Scheele J. Hepatectomy for liver metastases. Br J Surg 1993; 80:274-276.
3. Fortner JG, Silva JS, Golbey RB, et al. Multi-variate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 1984; 199:306-16.
4. Adson MA, Van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984; 119:647-651.
5. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma mestastases: a multi-instituional study of indications for resection. Surgery 1988; 103:278-288.
6. Nordlinger B, Jaeck D, Guiguet M, et al. Traitement des métastases hépatiques des cancers colorectaux. Monographies de l'Association Française de Chirurgie (AFC). Paris, France: Springer Verlag; 1992:129-146.
7. Scheele J, Slang R, Allendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg 1995; 19:59-71.
8. Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994; 330:1136-1139.
9. Chang AE, Schneider PD, Sugarbaker Ph, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206:685-693.
10. Caussanel JP, Levi F, Brienza S, et al. Phase I trial of 5-day continuous venous infusion of oxaliplatinum at circadian-modulated vs constant rate. J Natl Cancer Inst 1990; 82:1046-1050.
11. Levi F, Misset JL, Brienza S, et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Cancer 1992; 69:893-900.
12. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47:207-214.
13. Bismuth H, Castaing D, Traynor O. Surgery for synchronous hepatic metastases of colorectal cancer. Scand J Gastroenterol 1988; 149:144-149.
14. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982; 6:3-9.
15. Bismuth H, Chiche L. The development of segmental hepatic resection. Ann Surg 1993 (Surgical Residents Newsletter); 218:suppl 4, no 7.
16. Azoulay D, Raccuia JS, Castaing D, et al. Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg 1995; 181:267-269.
17. Fowler WC, Eisenberg BL, Huffman JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol 1992; 51:122-125.
18. Elias D, Lasser Ph, Rougier Ph, et al. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995; 180:213-219.
19. Scheele J, Strangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990; 77:1241-1246.
20. Bengtsson G, Carlsson G, Hafstrom L, et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141:586-589.
21. Moertel CG. Current concepts in cancer chemotherapy of gastrointestinal cancer. N Engl J Med 1978; 299:1049-1052.
22. Poon MA, O'Connell MJ, Moertel CG, et al. Chemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989; 7:1407-1417.
23. Erlichman C, Fine S, Wong A, Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988; 6:469-475.
24. Petrelli N, Herrera L, Rustum Y, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 1987; 5:1559-1565.
25. Scheithauer W, Rosen H, Kornek GV, et al. Randomised comparison of combination chemotherapy plus supportivce care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 1993; 306:752-755.
26. Stangl R, Altendorf-Hofmann A, Charnley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343:1405-1410.
27. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344:1255-1260.
28. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996; 88:252-258.
29. Pichlmayr R, Grosse G, Hauss J, et al. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg 1990; 77:21-26.
30. Hannoun L, Balladur P, Delva E, et al. Chirurgie "ex situ-in vivo" du foie: une nouvelle technique en chirurgie hépatique. Gastroenterol Clin Biol 1991; 15:758-761.
31. Bertheault-Cvitkovic F, Jami A, Ithzaki M, et al. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5 fluorouracil and folinic acid in patients with metastatic colorectaf cancer. J Clin Oncol 1996 (in press).